AtCor Medical Buy or Sell Recommendation

    Macroaxis provides AtCor Medical Holdings Limited buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AtCor Medical positions. The advice algorithm takes into account all of AtCor Medical Holdings Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AtCor Medical buy-and-hold prospective. Check also Trending Equities.

    Time Horizon

    Risk Tolerance

    Execute Advice
    AtCor Medical Holdings Limited -- USA Stock  

    USD 0.025  0.00  0.00%

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding AtCor Medical Holdings Limited is 'Not Rated'.
    For the selected time horizon AtCor Medical Holdings Limited has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
    We provide buy or sell recommendation to complement the latest expert consensus on AtCor Medical Holdings Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at this particular time. To make sure AtCor Medical Holdings is not overpriced, please confirm all AtCor Medical Holdings Limited fundamentals including its Revenue, Book Value Per Share and the relationship between Price to Earning and Net Income . As AtCor Medical Holdings appears to be a penny stock we also recommend to validate its Price to Earning numbers.
    Not Rated
    Alpha Finder
    Use alpha and beta coefficients to find investment opportunities after accounting for the risk
    Find Alpha
    Equity Screener
    Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
    Research Equities
    Insiders Screener
    Find insiders across different sectors to evaluate their impact on performance and growth of their entities
    Research Insiders